Aug 2026
Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults.
BACKGROUND Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.
· NEJM Evidence · 1 citation